SEC Comment Letter for Tiziana Life Sciences Ltd (TLSA) (CIK 0001723069) (TLSA) — Feb 1, 2021
Tiziana Life Sciences Ltd (TLSA) (CIK 0001723069)
Date: Feb. 1, 2021 · CIK: 0001723069 · Accession: 0000000000-21-001212
AI Filing Summary & Sentiment
File numbers found in text: 333-252441
Letter
United States securities and exchange commission logo February 1, 2021 Kunwar Shailubhai Chief Executive Officer Tiziana Life Sciences plc 3rd Floor, 11-12 St James’s Square London SW1Y 4LB United Kingdom Re:Tiziana Life Sciences plc Registration Statement on Form F-3 Filed January 26, 2021 File No. 333-252441 Dear Mr. Shailubhai: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Deanna Virginio at 202-551-4530 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jeffrey Fessler, Esq.
Show Raw Text
United States securities and exchange commission logo
February 1, 2021
Kunwar Shailubhai
Chief Executive Officer
Tiziana Life Sciences plc
3rd Floor,
11-12 St James’s Square
London SW1Y 4LB
United Kingdom
Re:Tiziana Life Sciences plc
Registration Statement on Form F-3
Filed January 26, 2021
File No. 333-252441
Dear Mr. Shailubhai:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Deanna Virginio at 202-551-4530 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Jeffrey Fessler, Esq.